MetaCap

Boundless Bio Statistics

NASDAQ: BOLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.32-0.06 (-2.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Boundless Bio by the numbers

Boundless Bio has a market capitalization of $54.8 million based on 23.61M shares outstanding. With trailing EPS of $-2.46, Boundless Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.1% below its 50-day average and 15.7% above its 200-day average.

Average daily trading volume is 131.34K shares, or about $304,709 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BOLD valuation vs. peer median

BOLD compared with the median of 8 peer companies
MetricBOLDPeer medianDifference
Market cap$54.78M$54.20M+1%
Avg. volume131.34K89.39K+47%

Peer median across 8 companies: AZR, XLO, KZIA, CTOR, IBIO, XBIT, TENX, LFVN.

Valuation

Price and trading

Previous close
2.38
Open
2.35
Day range
2.28 – 2.39
52-week range
0.961 – 3.16
52-week change
+105.31%
Beta
—
Volume
147.87K

Dividends and events

Additional statistics

Market Cap
54.78M
Forward Pe
-3.09
Eps
-2.46
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.16
Week52 Low
0.96
Avg Volume
131.34K
Shares Outstanding
23.61M
Ma50
2.52
Ma200
2.00
Pct From52w High
-26.68%
Pct From52w Low
141.42%

Related